Asarina Pharma Q3’19: Towards ph IIb read-out

Research Note

2019-11-20

11:06

This is a short research note on Asarina Pharma’s Q3’19 interim report.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.